Astrana Health Inc.

Healthcare US AMEH

NoneUSD
-(-%)

Last update at 2024-06-04T03:31:40.429333Z

Day Range

--
LowHigh

52 Week Range

35.9645.71
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.00000M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 86.62M 77.75M 178.43M 25.84M 82.63M
Minority interest 1.48M 24.56M 84.45M 3.56M 49.43M
Net income 49.05M 49.29M 122.32M 14.12M 10.84M
Selling general administrative 77.67M 62.08M 49.12M 41.48M 43.35M
Selling and marketing expenses - - - - -
Gross profit 193.31M 171.23M 143.01M 87.60M 153.55M
Reconciled depreciation 17.54M 17.52M 18.35M 18.75M 19.30M
Ebit 104.27M 98.18M 80.50M 32.42M 86.99M
Ebitda 133.35M 109.21M 106.44M 50.85M 106.29M
Depreciation and amortization 29.09M 11.03M 25.93M 18.43M 19.30M
Non operating income net other -9.72900M -15.03700M 107.42M -1.84678M -5.24452M
Operating income 104.27M 98.18M 80.50M 32.42M 88.43M
Other operating expenses 1033.73M 669.20M 601.72M 521.00M 422.45M
Interest expense 7.92M 5.39M 9.50M 4.73M 0.56M
Tax provision 36.09M 28.45M 56.11M 8.17M 22.36M
Interest income 1.98M 1.57M 2.81M 2.02M 1.26M
Net interest income -5.94400M -3.82300M -6.68600M -2.70938M 0.70M
Extraordinary items - - - - -
Non recurring - - - 0.63M 7.69M
Other items - - - - -
Income tax expense 36.09M 28.45M 56.11M 8.17M 22.36M
Total revenue 1138.00M 767.37M 682.23M 555.41M 514.68M
Total operating expenses 89.05M 73.05M 62.51M 53.19M 61.32M
Cost of revenue 944.68M 596.14M 539.21M 467.80M 361.13M
Total other income expense net -17.64900M -20.43100M 97.92M -6.58004M -10.30202M
Discontinued operations - - - - -
Net income from continuing ops 50.53M 49.29M 122.32M 17.67M 60.27M
Net income applicable to common shares 49.05M 73.86M 37.87M 14.12M 10.84M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 933.36M 963.90M 852.36M 817.49M 728.71M
Intangible assets 71.65M 76.86M 82.81M 86.98M 103.01M
Earning assets - - - - -
Other current assets 17.45M 14.80M 85.85M 16.75M 10.39M
Total liab 522.59M 395.21M 336.36M 372.34M 367.65M
Total stockholder equity 614.22M 552.82M 454.55M 330.82M 191.55M
Deferred long term liab - 3.04M 9.13M 10.96M 18.27M
Other current liab 125.60M 84.39M 40.19M 42.05M 54.63M
Common stock - 0.05M 0.04M 0.04M 0.04M
Capital stock 0.05M 0.05M 0.04M 0.04M 0.04M
Retained earnings 243.13M 192.68M 143.63M 69.77M 31.90M
Other liab - 23.30M 23.90M 10.96M 18.27M
Good will 278.83M 275.68M 253.04M 239.05M 238.51M
Other assets - 6.06M 6.50M 55.29M 2.43M
Cash 293.81M 288.03M 233.10M 193.47M 103.19M
Cash and equivalents - - - - -
Total current liabilities 218.67M 147.33M 115.37M 114.99M 105.42M
Current deferred revenue - 0.53M 16.80M 12.99M 8.89M
Net debt - -58.66300M -32.11400M 67.08M 153.36M
Short term debt - 4.79M 3.90M 14.17M 12.59M
Short long term debt 19.50M 0.62M 0.78M 10.89M 9.50M
Short long term debt total - 229.36M 200.98M 260.56M 256.55M
Other stockholder equity - 360.10M 310.88M 261.01M 159.61M
Property plant equipment - 128.98M 68.63M 48.46M 26.38M
Total current assets 461.51M 435.14M 398.78M 338.58M 329.07M
Long term investments 32.17M 40.30M 42.61M 47.92M 28.43M
Net tangible assets - 213.97M 118.70M 119.02M 18.76M
Short term investments 2.50M 5.57M 53.42M 67.69M 116.54M
Net receivables 135.76M 126.75M 93.63M 60.66M 98.95M
Long term debt 258.94M 203.39M 182.92M 230.21M 232.17M
Inventory - - -67.21700M - -
Accounts payable 9.07M 57.63M 54.48M 45.78M 29.31M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 2.19M 5.94M 0.09M 0.79M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -16.02318M
Additional paid in capital - - - - -
Common stock total equity - 0.05M 0.04M 0.04M 0.04M
Preferred stock total equity - - - - -
Retained earnings total equity - 192.68M 143.63M 69.77M 31.90M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 2.22M 6.06M 5.93M 19.41M 2.43M
Deferred long term asset charges - - - - -
Non current assets total 471.85M 528.77M 453.58M 478.91M 399.64M
Capital lease obligations 42.58M 25.36M 17.29M 19.45M 14.88M
Long term debt total - 203.39M 182.92M 230.21M 232.17M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 34.28M 32.37M 107.96M -129.69545M -23.60775M
Change to liabilities 18.80M 3.22M 6.82M -13.87921M -10.11166M
Total cashflows from investing activities -7.11300M 16.54M 95.49M -180.63064M -25.18282M
Net borrowings -0.82800M -57.96500M -0.10500M 281.35M 7.41M
Total cash from financing activities -20.08500M -47.74800M -51.69600M 163.33M -11.17634M
Change to operating activities 36.13M -18.19900M -1.22000M -21.50909M -48.54002M
Net income 50.53M 49.29M 122.32M 17.67M 60.27M
Change in cash 54.93M 39.13M 89.96M -3.62654M -10.86312M
Begin period cash flow 233.10M 193.97M 104.01M 107.64M 118.50M
End period cash flow 288.03M 233.10M 193.97M 104.01M 107.64M
Total cash from operating activities 82.13M 70.33M 46.16M 13.67M 25.50M
Issuance of capital stock 0.00000M 40.13M 0.00000M 0.75M 0.20M
Depreciation 17.54M 17.52M 18.35M 18.75M 19.30M
Other cashflows from investing activities -18.45700M 0.06M -11.30400M -49.89351M -0.40500M
Dividends paid -14.03000M -31.08900M -51.31900M -61.71737M 17.76M
Change to inventory - - -5.81100M -29.56291M -11.75599M
Change to account receivables -36.96300M -21.63400M 3.01M 9.28M -28.62630M
Sale purchase of stock -9.25000M -5.73900M -0.53700M -7.56968M -5.04764M
Other cashflows from financing activities 7.62M 187.48M -1.03700M 286.98M 12.02M
Change to netincome -3.70900M -1.99700M -106.66800M 2.27M 8.97M
Capital expenditures 22.94M 19.22M 1.16M 1.04M 1.17M
Change receivables -28.76700M -26.79600M 15.60M -5.80085M -28.62630M
Cash flows other operating 26.80M 4.92M -11.61000M -5.34146M -24.31112M
Exchange rate changes - - - - -
Cash and cash equivalents changes 54.93M 39.13M 89.96M -3.62654M -10.86312M
Change in working capital -9.58300M -20.12100M 10.81M -22.77152M -63.04907M
Stock based compensation 16.10M 6.75M 3.38M 1.55M 1.44M
Other non cash items 15.22M 22.85M -102.08400M 5.27M 15.88M
Free cash flow 59.19M 51.11M 45.00M 12.63M 24.33M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
AMEH
Astrana Health Inc.
- -% - - - - -
HCA
HCA Holdings Inc
-0.84 0.22% 386.05 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR
0.21 1.71% 12.49 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA
- -% 37.73 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc
- -% 5.10 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

Key Executives

Name Title Year Born
Dr. Kenneth T. Sim M.D. Exec. Chairman 1954
Dr. Thomas S. Lam M.D., M.P.H. Pres, Co-CEO & Director 1949
Mr. Brandon Sim Co-Chief Exec. Officer 1994
Dr. WaiChow Young M.D. Chief Admin. Officer 1947
Mr. Chan Basho Chief Strategy Officer & Interim CFO NA
Mr. John Vong Chief Accounting Officer 1973
Dr. Jeremy R. Jackson M.D. Chief Quality Officer NA
Mr. Neil Ahuja Pres of Provider Solutions NA
Yubin Park Chief Analytics Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.